<DOC>
	<DOCNO>NCT00671554</DOCNO>
	<brief_summary>The purpose study determine treatment autologous cellular vaccine , Melaxin , combination Bacillus Calmette-Guerin ( BCG ) injection effective Stage IV malignant melanoma .</brief_summary>
	<brief_title>Trial Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin ( BCG ) Treat Malignant Melanoma</brief_title>
	<detailed_description>Chemotherapy immunotherapy main therapy metastatic melanoma hope prolong survival . The ideal immunotherapy would consist professional antigen-presenting cell , dendritic cell , entire repertoire tumor antigens inside . The best way achieve create autologous hybrid fusion cell dendritic cell tumor cell . In study , melanoma tumor tissue surgically remove patient disassociate single cell , irradiate fuse dendritic cell produce culture patient 's blood monocyte . Prior electrofusion procedure , tumor cell stain red dendritic cell stain green . After fusion , uniquely color fused cell , dendritomas , separate unfused cell use fluorescence activate cell sorter . This highly purified population divide 4 dos contain 250,000 dendritomas frozen . Each dose thaw , dilute 1 milliliter ( ml ) Sterile Saline Injection contain 5 percent ( % ) human serum albumin administer subcutaneously ( SQ ) lymph node bed patient every 4 week . A separate injection Bacillus Calmette-Guerin ( BCG ) administer area within 10 minute dendritoma injection . The safety efficacy therapy evaluate 25 patient .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Ability give inform consent Male female patient whose age &gt; 18 year age Histological document Stage IV malignant melanoma ( American Joint Committee Cancer ( AJCC ) sixth edition ) Pathology report tumor specimen verify melanoma diagnosis Free infection Hemoglobin &gt; 9.0 gram per deciliter ( gm/dL ) , White Blood Cells ( WBC ) &gt; 3000/ cubic millimeter ( mm3 ) , platelets &gt; 100,000mm3 Liver function test le 2 time upper limit normal reference range test laboratory Adequate cardiac functionany evidence ischemic heart disease demonstrate history , physical , EKG require referral cardiologist evaluation clearance prior protocol therapy No immunotherapy within past 3 month A minimum 4 dos lotreleased , autologus Melaxin ( 1.0 million dendritomas ) Other malignancy past 5 year exception nonmelanoma skin cancer carcinoma situ cervix Has receive immunosuppressive agent within 30 day prior treat Creatinine &gt; 2.5 milligram per deciliter ( mg/dL ) currently dialysis Positive serum pregnancy test , breastfeeding , plan conceive father father child period surround study describe informed consent . Women childbearing potential follow direction birth control Eastern Cooperative Oncology Group ( ECOG ) performance status great 3 Positive Rdonr panel ( Human Immunodeficiency virus ( HIV ) 1 , 2 ; Human Tlymphotropic virus ( HTLV1,2 ) ; Hepatitis B C ) History seizure disorder Brain metastasis progress within last 6 month No measurable disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Dendritic cell</keyword>
	<keyword>Cell therapy</keyword>
	<keyword>BCG vaccine</keyword>
</DOC>